Some studies also found that HIF-1α is remarkably downregulated in cervical cancer tissues after chemotherapy compared with before chemotherapy, suggesting that HIF-1α can be used as a potential biomarker to predict the sensitivity of cisplatin chemotherapy in cervical cancer [13]. Here, HIF1A is linked to cervical cancer.